PedAM
Pediatric Disease Annotations & Medicines
| Disease | interstitial lung disease |
| Symptom | C0242379|lung cancer |
| Sentences | 25 |
| PubMedID- 24702855 | Successful crizotinib rechallenge after crizotinib-induced interstitial lung disease in patients with advanced non-small-cell lung cancer. |
| PubMedID- 22114570 | Erlotinib achieved partial response in a non-small cell lung cancer patient with gefitinib-induced interstitial lung disease. |
| PubMedID- 25867370 | Correlation of spicule sign on computed tomography scans with peripheral lung cancers associated with interstitial lung disease and chronic obstructive pulmonary disease. |
| PubMedID- 21828236 | Background: inflammation and pulmonary diseases, including interstitial lung diseases, are associated with increased lung cancer risk. |
| PubMedID- 24267779 | Objective: the study objective was to examine the incidence, risk factors, and mortality rate of acute exacerbation of interstitial lung diseases in patients with lung cancer undergoing pulmonary resection in a large-scale multi-institutional cohort. |
| PubMedID- 25352311 | Objective: lung cancer patients with interstitial lung diseases (ilds) who have undergone pulmonary resection often develop acute exacerbation of interstitial pneumonia (ae) in the post-operative period. |
| PubMedID- 22977623 | We analyzed 22 patients diagnosed as having lung cancer with interstitial lung disease who underwent surgical treatment at the kitasato university hospital. |
| PubMedID- 20872562 | Serum kl-6 levels in lung cancer patients with or without interstitial lung disease. |
| PubMedID- 25563718 | Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease. |
| PubMedID- 25123334 | High exposure to erlotinib and severe drug-induced interstitial lung disease in patients with non-small-cell lung cancer. |
| PubMedID- 19657749 | interstitial lung disease in patients with small cell lung cancer. |
| PubMedID- 22233823 | Small cell lung cancer with interstitial lung disease (ild-sclc) is difficult to treat because of the risk of fatal pneumonitis. |
| PubMedID- 23676984 | interstitial lung disease associated with lung cancer treatment. |
| PubMedID- 24903079 | Increased lung cancer risk in patients with interstitial lung disease and elevated cea and ca125 serum tumour markers. |
| PubMedID- 25043209 | Association between baseline pulmonary status and interstitial lung disease in patients with non-small-cell lung cancer treated with erlotinib--a cohort study. |
| PubMedID- 25439777 | We evaluated the survival and predictors of survival after surgical resection in lung cancers in patients with interstitial lung diseases. |
| PubMedID- 24006127 | Acute exacerbation of interstitial lung disease with lung cancer after surgery: evaluation with 2--fluoro-2-deoxy-d-glucose positron emission tomography. |
| PubMedID- 26288223 | interstitial lung disease (ild) occurs in patients with non-small cell lung cancer receiving egfr inhibitors. |
| PubMedID- 26134440 | Purpose: to investigate the safety of intravenous topotecan monotherapy for relapsed small cell lung cancer (sclc) patients with pre-existing interstitial lung disease (ild). |
| PubMedID- 21623239 | The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer. |
| PubMedID- 23180119 | Chest-tube drainage is a sign of acute exacerbation of interstitial lung disease associated with lung cancer. |
| PubMedID- 24696125 | Purpose: the incidence of lung cancer in patients with interstitial lung disease (ild) is higher than in the general population; however, the clinical benefit of chemotherapy and the appropriate regimen for non-small-cell lung cancer (nsclc) patients with ild remain unclear. |
| PubMedID- 21480134 | Prediction of acute pulmonary complications after resection of lung cancer in patients with preexisting interstitial lung disease. |
| PubMedID- 21036764 | Carboplatin plus weekly paclitaxel treatment in non-small cell lung cancer patients with interstitial lung disease. |
| PubMedID- 25012241 | Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease. |
Page: 1